T1	Outcomes 360 375	adverse effects
T2	Outcomes 387 399	neutropenia.
T3	Outcomes 570 578	efficacy
T4	Outcomes 759 787	higher neutrophil production
T5	Outcomes 867 910	PegFeG-CSF induced higher neutrophil counts
T6	Outcomes 915 948	showed greater sustained activity
T7	Outcomes 1024 1057	sustainable neutrophil production
T8	Outcomes 1138 1164	of neutralizing antibodies
T9	Outcomes 1203 1236	developed neutralizing antibodies
T10	Outcomes 1404 1431	HuG-CSF-induced neutropenia
T11	Outcomes 1444 1469	normal neutrophil numbers
